NEW YORK, Oct. 16 – Celera Genomics and Axys Pharmaceuticals have planned “a special meeting” on Nov. 16 at 1:00 p.m. EST to discuss the proposed acquisition of Axys by Celera’s parent company Applera, the companies announced on Tuesday.

The meeting will be held at Axys' headquarters in South San Francisco, Calif. Proxy statement for the meeting are expected to be mailed on or about Oct. 16 to Axys stockholders of record as of Oct. 1, 2001.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Science speaks with the University of Michigan's Jedidiah Carlson, who has tracked population genetic discussions at white nationalist sites.

Gene therapies could qualify for a faster US Food and Drug Administration approval process, according to Stat News.

NPR reports that the US House of Representatives has passed a bill to enable terminally ill patients access to experimental drugs.

In Genome Research this week: inversion variants mapped in human, non-human primate genomes; transcriptome profiling of maize, sorghum; and more.